You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

What’s New in the Drug Formulary

All new and updated drug and regimen monographs, patient information sheets, as well as safety and advice documents added to the Drug Formulary within the last 30 days are available here.

Drug

Published Date: 15 Feb 2018

Updated
Feb 2018
Drug

Published Date: 14 Feb 2018

Revision Summary: edited distribution, adverse effects, dosage with hepatic impairment, administration, precautions, and monitoring sections
Updated
Feb 2018
Drug

Published Date: 14 Feb 2018

Updated
Feb 2018
Regimen

Published Date: 14 Feb 2018

Revision Summary: noted topotecan as "unfunded"
Updated
Feb 2018
Regimen

Published Date: 13 Feb 2018

Revision Summary: aligned disease site with ST-QBP; removed bevacizumab administration sequence
Updated
Feb 2018
Regimen

Published Date: 13 Feb 2018

Revision Summary: aligned mesna dosing with ST-QBP; modified intents
Updated
Feb 2018
Regimen

Published Date: 13 Feb 2018

Updated
Feb 2018
Regimen

Published Date: 13 Feb 2018

Revision Summary: added trametinib supplementary public funding info
Updated
Feb 2018
Drug

Published Date: 13 Feb 2018

Updated
Feb 2018
Regimen

Published Date: 12 Feb 2018

Revision Summary: Updated funding information to indicate that a universal compassionate access program is available
Updated
Feb 2018
Regimen

Published Date: 08 Feb 2018

Revision Summary: removed bevacizumab sequence of administration
Updated
Feb 2018
Regimen

Published Date: 08 Feb 2018

Revision Summary: removed bevacizumab sequence of administration
Updated
Feb 2018